English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [4248]
News [13370]
Articles [52]
Editorials [10]
Conferences [236]
elearning [4]
Implantable device uses ultrasound to improve drug delivery to the brain
Implantable device uses ultrasound to improve drug delivery to the brain
Researchers discover new strategy to target obesity and reduce the risk of cancer
Researchers discover new strategy to target obesity and reduce the risk of cancer
AI-based computer model offers new weapon against hard-to-treat cancers
AI-based computer model offers new weapon against hard-to-treat cancers
ESMO 2026: Sacituzumab tirumotecan effective at decreasing recurrence of and death from endometrial cancer
ESMO 2026: Sacituzumab tirumotecan effective at decreasing recurrence of and death from endometrial cancer
How have US diagnostic and treatment decisions for prostate cancer changed in recent years?
How have US diagnostic and treatment decisions for prostate cancer changed in recent years?
ESMO 2026: New targeted therapy improved survival for patients with KRAS-mutated lung cancer
ESMO 2026: New targeted therapy improved survival for patients with KRAS-mutated lung cancer
Standard kidney function tests underestimate chronic kidney disease in people with cancer
Standard kidney function tests underestimate chronic kidney disease in people with cancer
ESMO 2026: Immunotherapy combination extends survival in advanced endometrial cancer
ESMO 2026: Immunotherapy combination extends survival in advanced endometrial cancer
ESMO 2026: Adding abiraterone to ADT and docetaxel improves survival in metastatic prostate cancer
ESMO 2026: Adding abiraterone to ADT and docetaxel improves survival in metastatic prostate cancer
ESMO 2026: Novel cancer immunotherapy drug generates promising clinical trial results
ESMO 2026: Novel cancer immunotherapy drug generates promising clinical trial results
<12345…1337>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2026 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top